Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
Holding SNSE?
Track your performance easily

Sensei Biotherapeutics (SNSE) Financial Statements

180 Followers

Sensei Biotherapeutics Financial Overview

Sensei Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.179; its P/E ratio is -0.46; Sensei Biotherapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 94.00K$ 276.00K--
Gross Profit-$ 94.00K$ 276.00K--
EBIT$ -7.12M$ -3.05M-$ -7.09M$ -9.35M
EBITDA$ -6.40M$ -2.35M-$ -6.76M$ -8.66M
Net Income Common Stockholders$ -7.14M$ -7.99M$ -7.41M$ -7.12M$ -9.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 52.29M$ 58.08M$ 65.76M$ 72.01M$ 78.84M
Total Assets$ 59.80M$ 66.69M$ 74.37M$ 81.66M$ 89.58M
Total Debt$ 5.05M$ 5.64M$ 6.21M$ 6.77M$ 7.26M
Net Debt$ -47.24M$ -52.44M$ -59.55M$ -65.24M$ -71.58M
Total Liabilities$ 7.61M$ 8.22M$ 9.48M$ 10.66M$ 10.38M
Stockholders Equity$ 52.19M$ 58.47M$ 64.89M$ 71.00M$ 79.20M
Cash Flow-
Free Cash Flow$ -5.90M$ -7.65M-$ -4.66M$ -9.33M
Operating Cash Flow$ -5.79M$ -7.62M$ -6.16M$ -4.66M$ -9.46M
Investing Cash Flow$ 6.91M$ 5.77M$ 8.26M$ 8.31M$ 19.53M
Financing Cash Flow$ -180.00K$ -209.00K$ -431.00K$ -2.53M$ -7.95M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

Sensei Biotherapeutics Debt to Assets

Sensei Biotherapeutics Cash Flow

Sensei Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis